Dendritic Cells and Cancer Immunity

Overview

Journal Trends Immunol

Specialty Allergy & Immunology

Date 2016 Oct 30

PMID 27793569

Citations 414

Authors

Alycia Gardner

Brian Ruffell

Affiliations

Soon will be listed here.

Abstract

Dendritic cells (DCs) are central regulators of the adaptive immune response, and as such are necessary for T-cell-mediated cancer immunity. In particular, antitumoral responses depend on a specialized subset of conventional DCs that transport tumor antigens to draining lymph nodes and cross-present antigen to activate cytotoxic T lymphocytes. DC maturation is necessary to provide costimulatory signals to T cells, but while DC maturation occurs within tumors, it is often insufficient to induce potent immunity, particularly in light of suppressive mechanisms within tumors. Bypassing suppressive pathways or directly activating DCs can unleash a T-cell response, and although clinical efficacy has proven elusive, therapeutic targeting of DCs continues to hold translational potential in combinatorial approaches.

Citing Articles

Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model.

Inoue H, Hamasaki T, Inoue K, Nakao A, Ebi N, Minomo H Sci Rep. 2025; 15(1):8311.

PMID: 40064915 PMC: 11894063. DOI: 10.1038/s41598-025-91979-w.

The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides.

Bedi D, Hassan M, Yirsaw A, Vikas B, Datta P, Samuel T Mol Cell Oncol. 2025; 12(1):2471640.

PMID: 40051755 PMC: 11881837. DOI: 10.1080/23723556.2025.2471640.

Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).

Li Z, Deng L, Cheng M, Ye X, Yang N, Fan Z Int J Oncol. 2025; 66(3).

PMID: 39981904 PMC: 11844338. DOI: 10.3892/ijo.2025.5730.

Identification of signaling networks associated with lactate modulation of macrophages and dendritic cells.

Sangsuwan R, Thuamsang B, Pacifici N, Tachachartvanich P, Murphy D, Ram A Heliyon. 2025; 11(3):e42098.

PMID: 39975831 PMC: 11835580. DOI: 10.1016/j.heliyon.2025.e42098.

Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens.

Chen M, Jiang J, Chen H, Wu R, Xie W, Dai S J Immunother Cancer. 2025; 13(2).

PMID: 39915006 PMC: 11804190. DOI: 10.1136/jitc-2024-010150.

References

Mellman I, Steinman R . Dendritic cells: specialized and regulated antigen processing machines. Cell. 2001; 106(3):255-8. DOI: 10.1016/s0092-8674(01)00449-4. View

Le D, Wang-Gillam A, Picozzi V, Greten T, Crocenzi T, Springett G . Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol. 2015; 33(12):1325-33. PMC: 4397277. DOI: 10.1200/JCO.2014.57.4244. View

Vicari A, Chiodoni C, Vaure C, Ait-Yahia S, Dercamp C, Matsos F . Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med. 2002; 196(4):541-9. PMC: 2196048. DOI: 10.1084/jem.20020732. View

Tang M, Diao J, Gu H, Khatri I, Zhao J, Cattral M . Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling. Cell Rep. 2015; 13(12):2851-64. DOI: 10.1016/j.celrep.2015.11.053. View

Roland C, Lynn K, Toombs J, Dineen S, Gomika Udugamasooriya D, Brekken R . Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One. 2009; 4(11):e7669. PMC: 2766251. DOI: 10.1371/journal.pone.0007669. View

Muller T, Robaye B, Vieira R, Ferrari D, Grimm M, Jakob T . The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy. 2010; 65(12):1545-53. DOI: 10.1111/j.1398-9995.2010.02426.x. View

Palucka K, Banchereau J . Dendritic-cell-based therapeutic cancer vaccines. Immunity. 2013; 39(1):38-48. PMC: 3788678. DOI: 10.1016/j.immuni.2013.07.004. View

Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C . Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med. 2009; 15(10):1170-8. DOI: 10.1038/nm.2028. View

Swiecki M, Colonna M . The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015; 15(8):471-85. PMC: 4808588. DOI: 10.1038/nri3865. View

10.

Schietinger A, Philip M, Liu R, Schreiber K, Schreiber H . Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase. J Exp Med. 2010; 207(11):2469-77. PMC: 2964573. DOI: 10.1084/jem.20092450. View

11.

Joshi N, Akama-Garren E, Lu Y, Lee D, Chang G, Li A . Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. Immunity. 2015; 43(3):579-90. PMC: 4826619. DOI: 10.1016/j.immuni.2015.08.006. View

12.

Merad M, Sathe P, Helft J, Miller J, Mortha A . The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013; 31:563-604. PMC: 3853342. DOI: 10.1146/annurev-immunol-020711-074950. View

13.

Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A . Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007; 13(9):1050-9. DOI: 10.1038/nm1622. View

14.

Spranger S, Bao R, Gajewski T . Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature. 2015; 523(7559):231-5. DOI: 10.1038/nature14404. View

15.

Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F . Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity. 2016; 44(2):343-54. PMC: 4758865. DOI: 10.1016/j.immuni.2015.11.024. View

16.

Cubillos-Ruiz J, Silberman P, Rutkowski M, Chopra S, Perales-Puchalt A, Song M . ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell. 2015; 161(7):1527-38. PMC: 4580135. DOI: 10.1016/j.cell.2015.05.025. View

17.

Kawarada Y, Ganss R, Garbi N, Sacher T, Arnold B, Hammerling G . NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J Immunol. 2001; 167(9):5247-53. DOI: 10.4049/jimmunol.167.9.5247. View

18.

Pasparakis M, Vandenabeele P . Necroptosis and its role in inflammation. Nature. 2015; 517(7534):311-20. DOI: 10.1038/nature14191. View

19.

DuPage M, Mazumdar C, Schmidt L, Cheung A, Jacks T . Expression of tumour-specific antigens underlies cancer immunoediting. Nature. 2012; 482(7385):405-9. PMC: 3288744. DOI: 10.1038/nature10803. View

20.

Rizvi N, Hellmann M, Snyder A, Kvistborg P, Makarov V, Havel J . Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124-8. PMC: 4993154. DOI: 10.1126/science.aaa1348. View